The Hippo Pathway in Cancer and Fibrosis

Moderator: Dr. Liliana Attisano, Professor, Biochemistry, University of Toronto The identification and role of NUAKs in cancer and fibrosis: Youchen (Catherine) Song, Graduate Student (Dr. Liliana Attisano, University of Toronto) Targeting the Hippo Pathway – Identification of kinase inhibitors to block the tumour-promoting activity of YAP/TAZ: Dr. Methvin Isaac, Senior Scientific Advisor, Drug Discovery Program, OICR Targeting cancer with VT3989, the first-in-class and first-in-human TEAD auto-palmitoylation inhibitor: Dr. Tracy Tang, Head of Biology, Vivace Therapeutics